Verification and Validation Test Engineer
We are looking for a Verification and Validation Test Engineer to support Novocure’s product development activities through the design and execution of detailed, comprehensive, and well-structured verification tests.
In this role, you will translate product requirements into effective test procedures, develop test strategies and fixtures, execute tests, and document results and anomalies. You will work closely with engineering and quality team members in Israel and Portsmouth, NH, contributing directly to the robust verification of Novocure’s products.
This is a full-time, exempt position based in our Haifa office and reports to the Verification and Validation Manager.
Novocure is a company with a powerful mission: to extend the lives of people living with some of the most aggressive forms of cancer.
Here, your work will have a direct impact on patients and those who care about them. Join a team of passionate, collaborative people who support each other, challenge one another, and innovate together.
Here, you’ll connect, grow, and make a real difference. We’re a company with the drive of a startup and the strength that comes with 25 years of success.
Novocure operates at a rare crossroads, where advanced medical technology converges with cutting-edge biotechnology.
We are the only company to develop and commercialize Tumor Treating Fields (TTFields), a proprietary, groundbreaking therapy designed to disrupt cancer cell division.
With us, you will find a unique combination of laboratory research work alongside engineering development of advanced technologies.
This fusion of disciplines positions us as true pioneers in oncology innovation, leading a new frontier in the treatment of aggressive cancers.
Our patient-forward values

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.